Future Microbiology

Papers
(The H4-Index of Future Microbiology is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-07-01 to 2025-07-01.)
ArticleCitations
Effect of Rapamycin on Cryptococcus Neoformans : Cellular Organization, Biophysics and Virulence Factors88
Predicting of novel homoserine dehydrogenase inhibitors against Paracoccidioides brasiliensis : integrating in silico and i76
Therapeutic Potential of MiRNAS in Clostridioides Difficile Infection58
Propionylation of Fis K32 in Salmonella enterica serovar Typhi: a key modification affecting pathogenicity53
Repurposing Prokaryotic Clustered Regularly Interspaced Short Palindromic Repeats-Cas Adaptive Immune System to Combat Antimicrobial Resistance33
Cymbopogon Citratus Essential Oil: An Active Principle of Nanoemulsion Against Enterococcus Faecalis Root Canal Biofilm33
First Report of Rhino-Orbital-Cerebral Mucormycosis After COVID-19 Infection in Bulgaria25
Natural Bioactives Versus Synthetic Antibiotics for the Attenuation of Quorum Sensing-Regulated Virulence Factors of Pseudomonas Aeruginosa25
In vitro Activities of Antibiotic Combinations Against Mature Biofilms of Ventilator-Associated Pneumonia Isolates22
Akkermansia muciniphila improves gastric cancer treatment by modulating the immune microenvironment21
Sources, transmission and hospital-associated outbreaks of nontuberculous mycobacteria: a review21
Inflammation at the Crossroads of Helicobacter Pylori and COVID-1920
Roles of the components of the cag -pathogenicity island encoded type IV secretion system in Helicobacter pylori20
Hospital-Onset Bacteremia: Clinical and Regulatory Ramifications20
Effect of amikacin-humic acid combination on Acinetobacter baumannii biofilm: an in vitro and in silico stu18
Analysis of subgingival bacterial and fungal diversity in patients with peri-implantitis based on 16sRNA and internal transcribed spacer sequencing18
Novel automated AIMLAM for diagnosis of Mycobacterium tuberculosis17
Evaluation of the Potential Of Rejuveinix Plus Dexamethasone Against Sepsis17
0.11092901229858